Blood Stream Infections clinical trials

Explore recruiting blood stream infections clinical trials.

Recruiting blood stream infections studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Blood Stream Infections trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

C3601008 - A PHASE 2A MULTICENTER, OBSERVER-BLINDED, RANDOMIZED 2 ARM STUDY TO INVESTIGATE PHARMACOKINETICS, SAFETY, TOLERABILITY AND EFFICACY OF INTRAVENOUS AZTREONAM-AVIBACTAM ± METRONIDAZOLE COMPARED TO BEST AVAILABLE THERAPY (BAT) IN PEDIATRIC PARTICIPANTS 9 MONTHS TO LESS THAN 18 YEARS OF AGE WITH SERIOUS GRAM-NEGATIVE BACTERIAL INFECTIONS INCLUDING COMPLICATED INTRA-ABDOMINAL INFECTION

Hungary, Spain, Greece, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)

Germany

Phase III and phase IV (Integrated) EU CTIS Study details

Preemptive Treament with acyclovir in intubated and mechanically ventilated patients with Herpes simplex virus oropharyngeal reactivation and one or less organ failure (PTH2)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Blood Stream Infections trials by city

Blood Stream Infections clinical trials

Recruiting blood stream infections studies right now

CLABSI Prevention With Tissue Adhesive

The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units

Prophylactic Antibiotic Treatment in Hemodialysis

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Also recruiting in Europe

Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)

Preemptive Treament with acyclovir in intubated and mechanically ventilated patients with Herpes simplex virus oropharyngeal reactivation and one or less organ failure (PTH2)

Blood Stream Infections trials by city

Other conditions